Albumin anchored docetaxel lipid nanoemulsion for improved targeting efficiency – preparation, characterization, cytotoxic, antitumor and in vivo imaging studies

Drug Delivery

Volumn 23, Issue 4, 2016, Pages 1355-1363

  Muzammil Afzal, Syed ^a   Naidu, V G M ^b   Harishankar, N ^c   Kishan, Veerabrahma ^a  

^a KAKATIYA UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^c NATIONAL INSTITUTE OF NUTRITION   (India)

Author keywords

Albumin tagged docetaxel lipid emulsion; antitumor study; fluorescent imaging study; improved tumor delivery; tumor targeting

Indexed keywords

ALBUMIN; DOCETAXEL; LIPID EMULSION; ALBUMINOID; DRUG CARRIER; LIPID; NANOPARTICLE; TAXOID;

ADHERENT CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TARGETING; FEMALE; HELA CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROPHILICITY; IC50; IN VITRO STUDY; IN VIVO STUDY; LIMIT OF QUANTITATION; MCF 7 CELL LINE; MOLECULAR WEIGHT; MOUSE; NANOEMULSION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; ROOM TEMPERATURE; STOICHIOMETRY; SURFACE PROPERTY; TUMOR VOLUME; ZETA POTENTIAL; ANIMAL; C57BL MOUSE; CHEMISTRY; DRUG SCREENING; MEDICINAL CHEMISTRY; METABOLISM; TUMOR CELL LINE;

ALBUMINS; ANIMALS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; MICE; MICE, INBRED C57BL; NANOPARTICLES; TAXOIDS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84975298252     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1030715     Document Type: Article

References (36)

1. A.T.Chemmanur, G.Y.Wu. (2006). Drug evaluation: albuferon-alpha A — an antiviral interferon-alpha/albumin fusion protein. Curr Opin Investig Drugs 7:750–8
2. J.Ciccolini, J.Catalin, M.F.Blachon,. (2001). Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction. J Chromatogr B Biomed Sci Appl 759:299–306
3. N.Desai, V.Trieu, Z.Yao,. (2006). Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res 12:1317–24
4. C.Devika Nandan, P.Reshmi, U.Saji,. (2013). Therapeutic properties of boswellic acid nanoparticles in prostate tumor–bearing BALB/c mice model. J Nanopharm Drug Deliv 1:30–7
5. C.Fiehn, U.Muller-Ladner, S.Gay,. (2004). Albumin-coupled methotrexate (MTX-HSA) is a new antiarthritic drug which acts synergistically to MTX. Rheumatology 43:1097–105
6. K.Gao, J.Sun, K.Liu,. (2008). Preparation & characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev Ind Pharm 34:1227–37
7. C.D.Georgiou, K.Grintzalis, G.Zervoudakis,. (2008). Mechanism of Coomassie brilliant blue G-250 binding to proteins: a hydrophobic assay for nanogram quantities of proteins. Anal Bioanal Chem 391:391–403
8. M.Goutayer, S.Dufort, V.Josserand,. (2010). Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging. Eur J Pharm Biopharm 75:137–47
9. W.J.Gradishar, S.Tjulandin, N.Davidson,. (2005). Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 23:7794–803
10. M.R.Green, G.M.Manikhas, S.Orlov,. (2006). Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol 17:1263–8
11. C.P.Hollis, H.L.Weiss, M.Leggas,. (2013). Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. J Control Release 172:12–21
12. S.S.Q.Hussaini, H.Tanvirul, A.Amer, L.Xinli. (2014). Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano 8:5423–40
13. N.K.Ibrahim, B.Samuels, R.Page,. (2005). Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer. J Clin Oncol 23:6019–26
14. T.A.John, S.M.Vogel, C.Tiruppathi,. (2003). Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol 284:L187–96
15. T.H.Kim, H.H.Jiang, Y.S.Youn,. (2011). Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 403:285–91
16. F.Kratz, G.Ehling, H.M.Kauffmann,. (2007). Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl) hydrazone derivative of doxorubicin (DOXOEMCH), an albumin-binding prodrug of the anticancer agent doxorubicin. Hum Exp Toxicol 26:19–35
17. F.Kratz. (2008). Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132:171–83
18. Q.Liu, R.Li, Z.Zhu,. (2012). Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Int J Pharm 430:350–8
19. Y.Liu, J.Sun, H.Lian,. (2014). Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution. J Pharm Sci 103:1538–47
20. S.Muzammil Afzal, V.Kishan. (2013). Preparation, characterization and in vitro evaluation of stealth docetaxel lipid nanoemulsions for efficient cytotoxicity. IJDD 5:188–95
21. J.Porath, P.Flodin. (1959). Gel filtration: a method for desalting and group separation. Nature 183:1657–9
22. K.Prabhakar, S.Muzammil Afzal, G.Surendar,. (2012). Albumin coupled lipid nanoemulsions of diclofenac for targeted delivery to inflammation. Nanomed: Nanotechnol Biol Med 8:1162–71
23. M.Priyanka, T.Amruta, S.Anjali,. (2014). In situ synthesized BSA capped gold nanoparticles: effective carrier of anticancer drug methotrexate to MCF-7 breast cancer cells. Mater Sci Eng: C 34:158–67
24. Z.Shen, Y.Li, K.Kohama,. (2011). Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres. Pharmacol Res 63:51–8
25. J.Shougang, G.Xianfeng, Z.Xiuhua,. (2015). Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles. Drug Delivery 22:206–13
26. R.Sinha, G.J.Kim, S.Nie,. (2006). Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 5:1909–17
27. G.Stehle, A.Wunder, H.Sinn,. (1997). Pharmacokinetics of methotrexate-albumin conjugates in tumor bearing rats. Anticancer Drugs 8:835–44
28. A.Taheri, R.Dinarvand, F.Ahadi,. (2012). The in vivo antitumor activity of LHRH targeted methotrexate–human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice. Int J Pharm 431:183–9
29. A.Taitz, G.Petruzzelli, A.S.Pak,. (1995). Immune parameters of mice bearing human head and neck cancer. Cancer Immunol Immunother 40:283–91
30. C.Unger, B.Häring, M.Medinger,. (2007). Phase I and pharmacokinetic study of the (6-maleimidocaproyl) hydrazone derivative of doxorubicin. Clin Cancer Res 13:4858–66
31. A.A.van de Loosdrecht, R.H.Beelen, G.J.Ossenkoppele,. (1994). A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 174:311–20
32. S.Vandana, D.V.Kohli, S.K.Jain. (2005). Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil. J Drug Target 13:245–50
33. E.Varshika, K.Prabhakar, V.Kishan. (2009). Preparation, characterization and in vivo pharmacodynamic evaluation of parenteral diclofenac submicron lipid emulsions. PDA J Pharm Sci Technol 63:380–9
34. I.Venkateshwarlu, K.Prabhakar, A.Mubarak,. (2010). Development and in vitro cytotoxic evaluation of parenteral docetaxel lipid nanoemulsions for application in cancer treatment. PDA J Pharm Sci Technol 64:233–41
35. A.N.Vis, A.van der Gaast, B.W.van Rhijn,. (2002). A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy. Cancer Chemother Pharmacol 49:342–5
36. H.Zhang, J.Dou, Y.Zhai,. (2014). Advances in the formulations of noninjection administration of docetaxel. J Drug Target 22:87–94